Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: CuCo2S4 nanocrystals as a nanoplatform for photothermal therapy of arterial inflammation

Xing Zhang a, Junchao Liu a, Xinrui Yang a, Guanjie He b, Bo Li *a, Jinbao Qin *a, Paul R. Shearing b, Dan J. L. Brett b, Junqing Hu *acd and Xinwu Lu *a
aDepartment of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China. E-mail: boli@shsmu.edu.cn
bElectrochemical Innovation Lab, Department of Chemical Engineering, University College London, London WC1E 7JE, UK
cCollege of Materials Science and Engineering, Donghua University, Shanghai, 201620, China
dCollege of Health Science and Environmental Engineering, Shenzhen Technology University, 3002 Lantian Road, Pingshan District, Shenzhen 518118, China. E-mail: hu.junqing@dhu.edu.cn

Received 17th June 2019 , Accepted 17th June 2019

First published on 21st June 2019


Abstract

Correction for ‘CuCo2S4 nanocrystals as a nanoplatform for photothermal therapy of arterial inflammation’ by Xing Zhang et al., Nanoscale, 2019, 11, 9733–9742.


The authors have noticed that an incorrect image was used for the ‘Control’ liver image in Fig. 7. A corrected version of Fig. 7 is therefore given below.
image file: c9nr90141h-f7.tif
Fig. 7 Representative images of HE staining of the main visceral organs in the Apo E −/− mice treated with the CuCo2S4 NCs after the PTT. There were no significant differences in the heart, liver, spleen, lung, kidney and intestine between the CuCo2S4 + NIR group and PBS control group, and no obvious lesions such as injury or inflammation were observed. All scale bars = 100 μm.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2019
Click here to see how this site uses Cookies. View our privacy policy here.